Processa shareholders approve 10x increase in authorized shares, reverse split up to 1:50

Processa Pharmaceuticals, Inc.

Approved increase of authorized common shares from 100M to 1B (13.7M for, 3.0M against).
Approved reverse stock split at ratio 1:2 to 1:50, effective by Dec 31, 2026 (13.9M for).
Approved amendment to 2019 Omnibus Incentive Plan to increase shares available (13.6M for).
Adjournment proposal approved but not needed due to sufficient votes on substantive proposals.

item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.